Healthpeak Properties, Inc. (NYSE:DOC) Given Average Recommendation of "Hold" by Analysts

Key Points

• Analysts remain neutral on Healthpeak Properties: Eighteen analysts give the stock an average “Hold” rating, with a consensus 12-month price target of approximately $21.72.
• Healthpeak exceeded quarterly expectations, reporting $0.08 in earnings per share versus the $0.03 consensus estimate and revenue of $771.58 million, up 11.1% year over year.
• The REIT declared a monthly dividend of $0.1017 per share, representing an annualized yield of about 5.9%; institutional investors own 93.57% of the company’s stock.

Shares of Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) have been assigned an average rating of "Hold" from the eighteen analysts that are presently covering the company, MarketBeat.com reports. Fourteen analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year target price among analysts that have covered the stock in the last year is $21.7188.

A number of research firms recently weighed in on DOC. Morgan Stanley restated an "equal weight" rating and issued a $22.00 price target (up from $20.00) on shares of Healthpeak Properties in a report on Thursday, June 11th. Mizuho boosted their target price on Healthpeak Properties from $21.00 to $24.00 and gave the stock an "outperform" rating in a research report on Monday, July 6th. Raymond James Financial began coverage on Healthpeak Properties in a report on Wednesday, June 17th. They issued a "market perform" rating on the stock. Wall Street Zen upgraded Healthpeak Properties from a "sell" rating to a "hold" rating in a research report on Sunday, May 10th. Finally, Royal Bank Of Canada lifted their price target on Healthpeak Properties from $21.00 to $24.00 and gave the stock an "outperform" rating in a research note on Monday, August 10th.

Healthpeak Properties Stock Down 1.8%

Shares of NYSE DOC opened at $20.65 on Friday. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 1.06. Healthpeak Properties has a 52 week low of $15.70 and a 52 week high of $22.95. The firm has a 50-day moving average price of $21.55 and a 200 day moving average price of $19.33. The stock has a market capitalization of $14.24 billion, a price-to-earnings ratio of 59.00, a price-to-earnings-growth ratio of 2.59 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, topping analysts' consensus estimates of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The firm had revenue of $771.58 million for the quarter, compared to the consensus estimate of $725.64 million. During the same quarter in the previous year, the firm earned $0.46 earnings per share. The firm's revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Equities research analysts anticipate that Healthpeak Properties will post 1.77 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be paid a $0.1017 dividend. This represents a c) dividend on an annualized basis and a yield of 5.9%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties's dividend payout ratio is presently 348.57%.

Hedge Funds Weigh In On Healthpeak Properties

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. State Street Corp grew its position in shares of Healthpeak Properties by 1.8% in the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust's stock valued at $947,889,000 after purchasing an additional 895,460 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in Healthpeak Properties by 8.6% in the 4th quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust's stock valued at $493,251,000 after buying an additional 2,438,278 shares in the last quarter. Fuller & Thaler Asset Management Inc. lifted its stake in Healthpeak Properties by 19.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust's stock valued at $476,744,000 after buying an additional 4,776,056 shares in the last quarter. Geode Capital Management LLC grew its holdings in Healthpeak Properties by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust's stock valued at $312,959,000 after buying an additional 123,274 shares during the last quarter. Finally, Invesco Ltd. grew its holdings in Healthpeak Properties by 9.9% during the 4th quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust's stock valued at $294,244,000 after buying an additional 1,648,012 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source